Table 10.

Provides the information about the number of training data instances obtained after applying SMOTE for each of the 22 neurological ADRs.

Neurological ADR	SMOTE instances		No. of instances before applying SMOTE
	Training data (Positive outcome Yes)	Training data (Negative outcome No)	Training data (Positive outcome Yes)	Training data (Negative outcome No)
Arteritic anterior ischaemic optic neuropathy	628	730	3	730
Autonomic neuropathy	628	731	2	731
Nervous system disorder	612	731	2	731
Neuralgia	627	675	57	676
Neuritis	616	676	56	677
Neuritis retrobulbar	628	731	2	731
Neuroleptic malignant syndrome	640	693	40	693
Neurologic reaction	660	728	2	731
Neurological impairment	628	731	2	731
Neurological symptom	644	718	14	719
Neuromuscular block prolonged	612	731	731	2
Neuromyopathy	628	731	731	2
Neuropathy	576	637	96	637
Neuropathy peripheral	585	616	117	616
Neurosis	702	706	27	706
Neurotoxicity	702	706	27	706
Optic neuritis	609	705	29	704
Peripheral motor neuropathy	594	724	3	730
Peripheral sensorimotor neuropathy	628	731	2	731
Peripheral sensory neuropathy	620	713	20	713
Polyneuropathy	656	717	16	717
Post herpetic neuralgia	628	730	3	730